Utilizing proximity-based amplification technology, the assay combines the analyte specificity of high-affinity antibody-antigen binding with the signal detection and amplification capabilities of real-time PCR to achieve a simple yet powerful…
Utilizing proximity-based amplification technology, the assay combines the analyte specificity of high-affinity antibody-antigen binding with the signal detection and amplification capabilities of real-time PCR to achieve a simple yet powerful next-generation protein quantitation platform. A user-friendly workflow combined with intuitive software for analytics enables sample-to-answer in just 2 hours.
The IL-22, also known as the inducible factor derived from the T cell bound to the IL-10, is an alpha helical cytokine and is considered to be a member of the IFN-IL-10 family, which includes IL-19, IL-20, IL-24, IL-26, Il-28, IL-29 and interferons type I and II. The main source of L-IL-22 is activated T cells and NK cells. In humans, the IL-22 gene is found on the q arm of chromosome 12 and is structurally bound to l的IL10. The HIL-22 act by engaging the heterodimeric receptor complex composed of the primary receptor IL-22R1 and the accessory receptor IL-10R2. The IL-22R1 also binds the IL-20 and IL-24; the IL-10R2 also binds the IL-10, IL-27, IL-28 and IL-29. The binding of the IL-22 to its receptor complex induces signal transduction, particularly via the JAK-STAT channel. In addition to the membrane-bound IL-22R1/IL-10R2 complex, it has been found that a single-chain soluble IL-22 receptor called IL-22BP antagonizes IL-22 bonding and signalling. The IL-22 does not appear to directly influence immune cells and the main targets of cytokine appear to be non-immune cells, such as skin cells, digestive and respiratory systems, as well as hepatocytes and keratinocytes. The IL-22 was described as an effective cytokine of the Th17 lineage. With IL-17A and IL-17F, the IL-22 regulates the genes associated with innate skin immunity. All of the Th17, IL-17F, and IL-22 cells are co-expressed by Th17, but are regulated differently. The effects of the IL-22 include the induction of acute phase reagents and antimicrobial proteins, as well as increased keratinocyte mobility. The IL-22 is strongly expressed during chronic inflammation and has been found to activate intracellular kinases and transcription factors. The IL-22 is essential for the defence of the host against infections of extracellular pathogens and promotes wound healing reactions. The IL-22 is regulated at the top in activated T cells. The IL-22 has been reported as a mediator of the IL-23-induced acanthosis and skin inflammation by activation of STAT3.
High sensitivity-detect low levels of protein…
High sensitivity-detect low levels of protein with greater sensitivity than traditional methods
Broad dynamic range-≥5 logarithmic units...
Broad dynamic range-≥5 logarithmic units, minimizing sample dilutions to ensure they fall within the range
Small sample consumption-use 2–5 μL of sample…
Small sample consumption-use 2–5 μL of sample (compared to 75 μL for triplicate wells with other methods)
Fast, easy workflow-2 hours from sample to…
Fast, easy workflow-2 hours from sample to answer, with no wash steps
No proprietary instrument to purchase-runs on any…
No proprietary instrument to purchase-runs on any real-time PCR instrument
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17104313 |
| Specifications |
| Accession number | Cytokine Zcyto18; EGK_03903; it 22; inducible factor derived from the T cell bound to the IL-10; inducible factor derived from the T cell bound to the IL-10; IL-21; IL22; IL-22; Il22a; IL-22 A; IL-D110; ILN; Iltif; Il-TIF; ILTIF alpha; IL-TIF alpha; ILTIFI; interleukin; inducible factor |
| Dose range | 0.32 to 25.000 pg/ml |
| Sensitivity of the dosage | < 0.3 pg /ml |
| Product type | ELISA |
| For use with (equipment) | qPCR instruments |
| Genetic identification (Enter) | Q9JJY9 |
| Gene symbol(s) | IL22 |
| Contents of kits | Antibody-Conjugate Antibody-Conjugate B Test Dilution Stamp Antibody-Conjugate Standard Master Mix ligase |
| Quantity | 96 tests |
| Regulatory status | Use exclusively for research |
| Target | IL-22 |
| Test time | 30 min |
| Physical characteristics |
| Volume of sample | Plasma, 2-5 µl; serum, 2-5 µl; supernatant, 2-5 µl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 2 h |
Origin and customs
| Manufacturer ref. | A47434 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.